Back
Full-text
Journal article

Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry?

  • Edwards SE Department of Health Care Management, Berlin University of Technology, Straße des 17. Juni 135, 10623 Berlin, Germany. esuzi@hotmail.co.uk.
  • Morel CM Infection Control Programme, WHO Collaborating Centre, University of Geneva Hospitals and Faculty of Medicine, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. chantal.morel@unige.ch.
  • Busse R Department of Health Care Management, Berlin University of Technology, Straße des 17. Juni 135, 10623 Berlin, Germany. rbusse@tu-berlin.de.
  • Harbarth S Infection Control Programme, WHO Collaborating Centre, University of Geneva Hospitals and Faculty of Medicine, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. stephan.harbarth@hcuge.ch.
  • 2018-12-21
Published in:
  • Antibiotics (Basel, Switzerland). - 2018
antibiotic consumption
antibiotics
antimicrobial resistance
health economics
marketing
pharmaceutical industry
promotion
research and development incentives
sustainable use
English The development of antibiotics needs to be supported through new financial stimuli, including help from the public sector. In exchange for public support, industry should be asked to do what is in their power to help curb the inappropriate use of antibiotics. This work discusses key areas through which industry has an important influence on antibiotic consumption and where agreements can be made alongside financial incentives, even those intended to stimulate very early research. As long as the traditional unit sale-based business model for antibiotics remains in place, profit-making incentives will likely undermine efforts to sell and utilize antibiotics in a sustainable manner. In the short-term, while we try to come to a consensus on how best to fix the market, we need measures to prevent major over-selling and inappropriate promotion-especially for new, badly needed antibiotics that reach the market. This paper explores ways in which the pharmaceutical industry could help buttress sustainable antibiotic use while we search for more long-term, constructive, mutually-beneficial ways to organize the market.
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://sonar.ch/global/documents/232983
Statistics
Document views: 17 File downloads:
  • Full-text: 0